Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock
Stocks
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Shanghai S.E.
2026-08-25
|
5-day change | 1st Jan Change | ||
| 36.08 CNY | +1.01% |
|
+0.61% | -20.91% |
| Market Cap | 24.35B 3.62B 3.11B 2.92B 2.66B 5.03B 345B 5.05B 34.53B 13.38B 174B 13.6B 13.3B 577B | P/E 2026 * |
27.3x | P/E 2027 * | 23.8x |
|---|---|---|---|---|---|
| Enterprise Value | 24.35B 3.62B 3.11B 2.92B 2.66B 5.03B 345B 5.05B 34.53B 13.38B 174B 13.6B 13.3B 577B | EV / Sales 2026 * |
4.94x | EV / Sales 2027 * | 4.55x |
| Free-Float |
31.71% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +1.01% | ||
| 1 week | +0.61% | ||
| Current month | -5.77% | ||
| 1 month | -1.45% | ||
| 3 months | -9.69% | ||
| 6 months | -18.19% | ||
| Current year | -20.91% |
| 1 week | 35.11 |  | 36.46 |
| 1 month | 35.11 | | 38.92 |
| Current year | 34.7 | | 48.2 |
| 1 year | 34.7 | | 50.95 |
| 3 years | 23.4 | | 50.97 |
| 5 years | 17.98 | | 56.26 |
| 10 years | 11.8 | | 56.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lei Wang
CEO | Chief Executive Officer | 55 | 2017-10-09 |
Hong Zhou
PRN | Corporate Officer/Principal | 56 | - |
Mai Wang
PRN | Corporate Officer/Principal | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Xiu Mei Guo
BRD | Director/Board Member | 44 | 2018-12-23 |
Mai Wang
BRD | Director/Board Member | 56 | - |
Hong Zhou
BRD | Director/Board Member | 56 | 2019-05-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.01% | +0.61% | -21.17% | +5.44% | 3.62B | |
| +1.01% | +1.01% | -13.78% | -5.57% | 13.34B | |
| +1.98% | +0.33% | -35.14% | -57.05% | 4.99B | |
| +1.85% | -5.05% | -6.75% | -2.34% | 4.63B | |
| +1.58% | -4.23% | -1.29% | -28.74% | 3.99B | |
| +2.21% | +3.87% | -6.13% | -3.71% | 3.43B | |
| -0.47% | -4.16% | -13.69% | +11.83% | 3.28B | |
| +0.86% | -3.04% | -19.63% | -15.55% | 2.43B | |
| +1.82% | -1.23% | -31.46% | -11.34% | 1.71B | |
| +0.46% | -0.30% | -16.93% | +24.57% | 1.66B | |
| Average | +1.23% | -1.14% | -16.60% | -8.25% | 4.31B | |
| Weighted average by Cap. | +1.25% | -0.84% | -15.50% | -10.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.93B 733M 629M 591M 540M 1.02B 69.95B 1.02B 6.99B 2.71B 35.29B 2.75B 2.69B 117B | 5.35B 796M 683M 641M 586M 1.11B 75.91B 1.11B 7.59B 2.94B 38.29B 2.99B 2.92B 127B |
| Net income | 1.04B 154M 132M 124M 113M 214M 14.7B 215M 1.47B 569M 7.41B 579M 566M 24.56B | 1.18B 176M 151M 142M 130M 245M 16.8B 246M 1.68B 651M 8.47B 661M 647M 28.07B |
| Net Debt | - | - |
Employees
3,890
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-26 | CN¥36.58 | +1.39% | 2,774,074 |
| 26-08-25 | CN¥36.08 | +1.01% | 1,841,912 |
| 26-08-24 | CN¥35.72 | +1.05% | 2,780,150 |
| 26-08-21 | CN¥35.35 | -2.56% | 3,129,900 |
| 26-08-20 | CN¥36.28 | +1.77% | 3,177,569 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
36.58
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600329 Stock
Select your edition
All financial news and data tailored to specific country editions
